The National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology® now include stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer. Developed and updated annually by nearly 950 clinical professionals, the guidelines help individuals involved in cancer care, including physicians, nurses, patients and their families, with the decision-making process intended to advance the fight against cancer. Consisting of 23 of the world’s leading cancer centers, the NCCN is dedicated to research that improves the quality of cancer care.
Our medical director Dr. Doug Widman says it’s exciting to see SBRT included in the 2014 NCCN prostate cancer guidelines as an emerging alternative treatment modality to conventional radiation. “When seeking treatment for prostate cancer, it’s important for men to educate themselves on the treatment options available for their diagnosis. For those who are candidates, SBRT is a nonsurgical alternative with little to no recovery time. Some men, particularly those who work or travel regularly, are drawn to these benefits of the treatment,” he said.
You can find additional information about the NCCN guidelines here.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.